Mesa Laboratories (NASDAQ:MLAB) CAO Sells $39,559.00 in Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) CAO Lyndsey Elizabeth Crennen sold 442 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $89.50, for a total value of $39,559.00. Following the transaction, the chief accounting officer owned 2,020 shares in the company, valued at approximately $180,790. This trade represents a 17.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Lyndsey Elizabeth Crennen also recently made the following trade(s):

• On Tuesday, June 16th, Lyndsey Elizabeth Crennen sold 118 shares of Mesa Laboratories stock. The shares were sold at an average price of $101.27, for a total transaction of $11,949.86.

Mesa Laboratories Price Performance

Shares of Mesa Laboratories stock opened at $98.15 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.29 and a debt-to-equity ratio of 0.78. The firm has a fifty day simple moving average of $101.79 and a 200-day simple moving average of $91.35. The stock has a market capitalization of $542.28 million, a price-to-earnings ratio of 81.79 and a beta of 0.94. Mesa Laboratories, Inc. has a 1-year low of $55.45 and a 1-year high of $113.99.

Mesa Laboratories (NASDAQ:MLAB) last posted its earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). The firm had revenue of $63.72 million during the quarter, compared to analyst estimates of $65.21 million. Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. During the same quarter in the previous year, the business posted ($1.31) earnings per share.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Friday, May 29th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Friday, May 29th. Mesa Laboratories’s dividend payout ratio (DPR) is currently 53.33%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 3rd. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Mesa Laboratories presently has a consensus rating of “Reduce” and an average target price of $94.00.

Hedge Funds Weigh In On Mesa Laboratories

Institutional investors and hedge funds have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. raised its stake in Mesa Laboratories by 5,366.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Mesa Laboratories during the 4th quarter worth about $27,000. Kestra Advisory Services LLC bought a new position in shares of Mesa Laboratories during the 4th quarter worth about $55,000. BNP Paribas Financial Markets increased its holdings in shares of Mesa Laboratories by 30.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock worth $69,000 after purchasing an additional 243 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Mesa Laboratories by 432.9% during the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock valued at $79,000 after buying an additional 684 shares during the last quarter. Institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.